Jan 30, 2024 7:05 am EST NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
Jan 2, 2024 7:05 am EST NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Dec 5, 2023 8:00 am EST NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
Nov 14, 2023 7:00 am EST NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
Oct 24, 2023 7:00 am EDT NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
Oct 17, 2023 9:20 am EDT NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
Jul 27, 2023 7:00 am EDT NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer
